genglob magazine


magazine by for generics, medicines and alternative treatments like ayurveda and traditional chinese

Indian Government allow legal generic cancer drug under TRIPS

India’s government for the first time will allow a generic-drug maker to produce and sell cheaper copies of a patented cancer medicine, a decision that pressures brand-name manufacturers to lower prices.Sorafenib - nexavar

Natco Pharma Ltd. (NTCPH) received a so-called compulsory license to make Bayer AG (BAYN)’s Nexavar, which goes by the generic name sorafenib, and will have to sell it at a 97 percent discount to Bayer’s existing product, India’s Controller General of Patents Designs and Trademarks said yesterday in a statement on its website. Read the rest of this entry »